Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126475461 | 12647546 | 1 | I | 20160706 | 20160812 | 20160812 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121991 | RANBAXY | 19.00 | YR | M | Y | 0.00000 | 20160812 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126475461 | 12647546 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 175 MG, DAILY | 75713 | 175 | MG | ||||||||
| 126475461 | 12647546 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | 75713 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126475461 | 12647546 | 1 | Major depression |
| 126475461 | 12647546 | 2 | Catatonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126475461 | 12647546 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126475461 | 12647546 | Dysarthria | |
| 126475461 | 12647546 | Motor dysfunction | |
| 126475461 | 12647546 | Sedation | |
| 126475461 | 12647546 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |